Test ID: MSH2K
MSH2 Known Mutation
Secondary ID 
A test code used for billing and in test definitions created prior to November 2011
83082
NY State Approved Indicates the status of NY State approval and if the test is orderable for NY State clients.
Yes
Useful For Suggests clinical disorders or settings where the test may be helpful
Diagnostic or predictive testing for Lynch syndrome/hereditary nonpolyposis colorectal cancer when an MSH2 or EPCAM mutation has been identified in a family member
Testing Algorithm Delineates situation(s) when tests are added to the initial order. This includes reflex and additional tests.
Special Instructions and Forms Describes specimen collection and preparation information, test algorithms, and other information pertinent to test. Also includes pertinent information and consent forms to be used when requesting a particular test
Method Name A short description of the method used to perform the test
Polymerase chain reaction (PCR)/DNA sequencing or dosage analysis (multiplex ligation-dependent probe amplification [MLPA] or Southern blot analysis) is utilized to test for the presence of a specific mutation previously identified in an affected family member.
(PCR is utilized pursuant to a license agreement with Roche Molecular Systems, Inc.)
Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name
MSH2 Known Mutation
Aliases Lists additional common names for a test, as an aid in searching
Colon Cancer gene testing
Hereditary Nonpolyposis Colorectal Cancer (HNPCC)
hMSH2 genotyping
HNPCC (Hereditary Nonpolyposis Colorectal Cancer) gene testing
Lynch Syndrome
MSH2 gene testing
TACSTD1
EPCAM
Hereditary Nonpolyposis Colorectal Cancer (HNPCC)
hMSH2 genotyping
HNPCC (Hereditary Nonpolyposis Colorectal Cancer) gene testing
Lynch Syndrome
MSH2 gene testing
TACSTD1
EPCAM
External
link
PDF
document
Excel
document
Word
document